enGene Holdings Inc., a clinical-stage genetic medicines company, has entered into an agreement to sell 6,758,311 of its common...

Odyssey Therapeutics, a clinical-stage biopharmaceutical company, is set to present promising data on its receptor-interacting protein kinase 2 (RIPK2)...

ABIONYX Pharma, a company focused on developing innovative therapies using recombinant human apoA-I, announced that its Phase 2b RACERS...

Precision BioSciences, a clinical-stage gene editing company, has announced a significant advancement in its quest to cure chronic hepatitis...

Researchers have developed a potential machine learning model that could personalize treatments for female pelvic floor disorders, specifically urinary...

In this interview, we speak with Dr. Stephen Deacon, Chief Scientific Officer at Pharmanovia, about the shift towards decentralized...

In a groundbreaking collaboration, Walgreens, AstraZeneca, and digital health company Evinova revealed at DPHARM 2024 that they have embarked on a...

The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practice (ACIP) has recommended expanding the...

AngioDynamics, a medical technology company specializing in vascular health and cancer treatment, has initiated a global registry study to...